Midkine anticorps (AA 22-143)

N° du produit ABIN2914868

Détail du produit anti-Midkine anticorps

Antigène: Midkine (MDK) (Midkine (Neurite Growth-Promoting Factor 2) (MDK))

Épitope: AA 22-143

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Midkine est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (fixed cells) (IF/ICC)

Purification: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogène: MK (Ala22-Asp143)

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 500 μg/mL

Buffer: PBS,  pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4 °C for frequent use. Aliquot and store at -20 °C for one year. Avoid repeated freeze/thaw cycles.

Détails sur Midkine

Antigène: Midkine (MDK) (Midkine (Neurite Growth-Promoting Factor 2) (MDK))

Autre désignation: Midkine (MDK Produits)

Synonymes: anticorps ARAP, anticorps MK, anticorps NEGF2, anticorps Mek, anticorps MK-B, anticorps PTF-alpha-1, anticorps mdk, anticorps midkine, anticorps negf2, anticorps RIHB, anticorps cb518, anticorps fb79b05, anticorps fj33b02, anticorps fj48a12, anticorps mdk2, anticorps plei2, anticorps wu:fb79b05, anticorps wu:fj33b02, anticorps wu:fj48a12, anticorps MK-A, anticorps PTF-alpha-2, anticorps X-PTF-alpha1, anticorps XMK, anticorps mdk-a, anticorps mdk-b, anticorps midkine, anticorps midkine L homeolog, anticorps midkine (neurite growth-promoting factor 2), anticorps midkine b, anticorps midkine S homeolog, anticorps MDK, anticorps Mdk, anticorps mdk.L, anticorps mdkb, anticorps mdk.S

UniProt: P21741

Pathways: Signalisation RTK, M Phase, Skeletal Muscle Fiber Development